Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Porin Insertion in the Outer Mitochondrial Membrane01:12

Porin Insertion in the Outer Mitochondrial Membrane

4.8K
Porins are beta-barrel proteins translocated to the mitochondrial outer membrane through the TOM complex into the intermembrane space. Porin precursors bind TIM chaperones within the intermembrane space and are guided to the Sorting and Assembly Machinery complex or SAM complex on the outer mitochondrial membrane.
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
4.8K
Protein Transport to the Outer Chloroplast Membrane01:11

Protein Transport to the Outer Chloroplast Membrane

2.4K
Chloroplast outer membrane proteins encoded by the nucleus are synthesized in the cytosol. Soon after synthesis, they bind cytosolic factors such as 14-3-3 protein and the Hsp70 chaperones that keep these precursors in an unfolded state until their translocation.
Two models describe the mechanism of precursor recognition and entry across the outer membrane through the TOC complex. Model 1 suggests the newly synthesized precursor binds to the TOC receptor 159 and forms a complex.
2.4K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

18.9K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
18.9K
Histone Modification02:32

Histone Modification

16.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.1K
Histone Modification02:32

Histone Modification

4.5K
4.5K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

9.4K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autophagy modulation in gynaecologic oncology: insights into immune regulation and therapeutic potential.

Frontiers in immunology·2026
Same author

Is a comprehensive root economics space a chimera?

Trends in ecology & evolution·2026
Same author

Pharmacovigilance evaluation of somatrogon-associated adverse events in real-world databases.

Endocrine connections·2026
Same author

CO<sub>2</sub>-Induced Reverse Lattice Oxygen Spillover on Pt/CeO<sub>2</sub> Enables Sulfur-Resistant Dry Reforming of Methane.

Angewandte Chemie (International ed. in English)·2026
Same author

Pathophysiological mechanisms of organ injury in Fabry disease: Update via multi-omics.

Genes & diseases·2026
Same author

Development and Validation of a Nomogram for Predicting Sepsis Risk in Patients with Non-Ventilator Hospital-Acquired Pneumonia.

Biomedicines·2026

Related Experiment Video

Updated: Jan 28, 2026

Size Exclusion Chromatography to Analyze Bacterial Outer Membrane Vesicle Heterogeneity
07:26

Size Exclusion Chromatography to Analyze Bacterial Outer Membrane Vesicle Heterogeneity

Published on: March 31, 2021

5.1K

Bioengineering modification and application of bacterial outer membrane vesicles.

Yedu Wen1, Yidi Si1, Xinni Jia1

  • 1Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China.

International Journal of Medical Sciences
|January 26, 2026
PubMed
Summary
This summary is machine-generated.

Outer Membrane Vesicles (OMVs), bacterial nanovesicles, show clinical promise for vaccines and drug delivery. Standardizing OMV production and modification is crucial for their therapeutic application.

Keywords:
OMVsbioengineering modificationsclinical applications

More Related Videos

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

13.9K
Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
08:34

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages

Published on: February 22, 2017

11.9K

Related Experiment Videos

Last Updated: Jan 28, 2026

Size Exclusion Chromatography to Analyze Bacterial Outer Membrane Vesicle Heterogeneity
07:26

Size Exclusion Chromatography to Analyze Bacterial Outer Membrane Vesicle Heterogeneity

Published on: March 31, 2021

5.1K
Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

13.9K
Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
08:34

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages

Published on: February 22, 2017

11.9K

Area of Science:

  • Microbiology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Outer Membrane Vesicles (OMVs) are nanovesicles secreted by Gram-negative bacteria.
  • OMVs are involved in bacterial processes like nutrient uptake and toxin delivery.
  • OMVs possess biocompatibility and immunogenic properties, suggesting therapeutic potential.

Purpose of the Study:

  • To review current research on the modification and application of OMVs.
  • To highlight the clinical potential of OMVs in various diseases.
  • To identify challenges and provide insights for OMV-based therapeutic development.

Main Methods:

  • Literature review of studies on OMV modification and applications.
  • Analysis of OMV properties relevant to therapeutic use.
  • Consolidation of findings on OMV-based treatments for tumors, autoimmune diseases, and infections.

Main Results:

  • OMVs demonstrate significant potential in vaccine development and antigen/drug delivery systems.
  • Applications span treatment of tumors, autoimmune diseases, and infectious diseases.
  • Challenges exist in standardizing OMV production and modification techniques.

Conclusions:

  • OMVs offer a promising platform for novel therapeutic strategies.
  • Further research and standardization are needed for clinical implementation.
  • OMV modification and application advancements can drive therapeutic innovation.